FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)

View source ↗

Summary

FDA approves Janssen's supplemental application for INVEGA HAFYERA (paliperidone palmitate), updating its labeling for schizophrenia in adults. The drug is a lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA HAFYERA (PALIPERIDONE PALMITATE)

Snippet

SUPPL AP for INVEGA HAFYERA (PALIPERIDONE PALMITATE)